Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis - Scorecard - MDSpire

Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis

  • By

  • Laís dos Santos

  • Thaís Martins Shehan

  • Candela Lang

  • Ricardo Sanchez Algarin

  • Ingrid Bezerra de Oliveira Ribeiro

  • Paulo Cesar Mattos Dourado de Mesquita

  • Guilherme Dagostin de Carvalho

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: A Systematic Review and Meta-Analysis of Adenosine Administration and Cardioversion in Pediatric Patients with Supraventricular Tachycardia

At a Glance

CategoryDetail
Condition
Key MechanismsAdenosine blocks atrioventricular nodal conduction, facilitating cardioversion. [Source needed]
Target Population
Care Setting

Key Highlights

  • Variability in initial dosing of adenosine exists across different clinical settings. [Source needed]
  • Suboptimal dosing may lead to delayed cardioversion and increased care escalation. [Source needed]

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • M
      • o
      • n
      • i
      • t
      • o
      • r
      • f
      • o
      • r
      • s
      • u
      • c
      • c
      • e
      • s
      • s
      • f
      • u
      • l
      • c
      • a
      • r
      • d
      • i
      • o
      • v
      • e
      • r
      • s
      • i
      • o
      • n
      • t
      • o
      • s
      • i
      • n
      • u
      • s
      • r
      • h
      • y
      • t
      • h
      • m
      • a
      • f
      • t
      • e
      • r
      • a
      • d
      • e
      • n
      • o
      • s
      • i
      • n
      • e
      • a
      • d
      • m
      • i
      • n
      • i
      • s
      • t
      • r
      • a
      • t
      • i
      • o
      • n
      • .
      • [
      • S
      • o
      • u
      • r
      • c
      • e
      • n
      • e
      • e
      • d
      • e
      • d
      • ]

      Risks

        Patient & Prescribing Data

        Children and adolescents under 18 years with SVT.

        Weight-based dosing of adenosine is critical for effective cardioversion.

        Clinical Best Practices

        • Consider distinct management strategies for specific substrates like WPW syndrome. [Source needed]

        Related Resources & Content

        Original Source(s)

        Related Content